Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-10-15 Purchase |
2024-10-15 5:49 pm |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
909,090 | $11 | $9,999,990 | 909,090 (Indirect) |
View |
| 2022-06-22 Purchase |
2022-06-24 4:27 pm |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
1,197,992 | $4.9 | $5,870,161 | 513,836 (Indirect Direct) |
View |
| 2021-05-21 Sale |
2021-05-25 7:20 pm |
Morphic Holding Inc. | MORF | Nashat Amir Director |
232,295 | $45.5 | $10,569,423 | 136,691 (Indirect) |
View |
| 2020-09-18 Purchase |
2020-09-22 5:10 pm |
Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner |
230,000 | $13 | $2,990,000 | 178,942 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-10-15 Conversion |
2024-10-15 5:49 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
20,962,046 | $0 | 909,090 (Indirect) |
View |
Ownership |
2024-10-10 9:05 pm |
N/A N/A |
Camp4 Therapeutics Corp | CAMP | Nashat Amir Director 10% Owner |
0 | $0 | 1,715,972 (Indirect) |
View |
| 2024-08-16 Equity Swap |
2024-08-20 7:11 pm |
N/A N/A |
Morphic Holding Inc. | MORF | Nashat Amir Director |
1,990,796 | $0 | 0 (Direct) |
View |
| 2024-06-04 Option Award |
2024-06-05 7:12 pm |
N/A 2034-06-03 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
23,168 | $0 | 23,168 (Direct) |
View |
| 2024-05-09 Other |
2024-05-13 4:17 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
611,988 | $0 | 749,160 (Indirect) |
View |
| 2023-12-27 Gift |
2023-12-29 4:40 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
21,333 | $0 | 2,274,080 (Direct) |
View |
| 2023-12-13 Other |
2023-12-15 4:26 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
1,223,976 | $0 | 1,467,883 (Indirect) |
View |
| 2023-11-20 Other |
2023-11-22 4:30 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
611,992 | $0 | 731,103 (Indirect) |
View |
| 2023-06-28 Other |
2023-06-30 7:12 pm |
N/A N/A |
Morphic Holding Inc. | MORF | Nashat Amir Director |
101,080 | $0 | 232,313 (Indirect) |
View |
| 2023-06-21 Option Award |
2023-06-22 7:20 pm |
N/A 2033-06-21 |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
36,000 | $0 | 36,000 (Direct) |
View |
| 2023-06-01 Option Award |
2023-06-02 7:04 pm |
N/A 2033-05-31 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
12,535 | $0 | 12,535 (Direct) |
View |
| 2022-05-18 Option Award |
2022-09-06 7:27 pm |
N/A 2032-05-17 |
Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner |
16,500 | $0 | 16,500 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 7:00 pm |
N/A 2032-06-07 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
17,550 | $0 | 17,550 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-02 7:08 pm |
N/A 2032-05-31 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-05-26 Option Award |
2022-05-27 4:34 pm |
N/A 2032-05-26 |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
28,000 | $0 | 28,000 (Direct) |
View |
| 2021-06-16 Option Award(A) |
2022-04-29 4:17 pm |
N/A 2031-06-16 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
9,910 | $0 | 9,910 (Direct) |
View |
| 2021-11-17 Other |
2021-11-19 4:32 pm |
N/A N/A |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
346,721 | $0 | 409,989 (Indirect) |
View |
| 2021-06-16 Option Award |
2021-06-17 7:12 pm |
N/A 2031-06-16 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2021-06-08 Option Award |
2021-06-10 5:29 pm |
N/A 2031-06-07 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2021-05-27 Option Award |
2021-06-01 4:11 pm |
N/A 2031-05-27 |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director |
7,800 | $0 | 7,800 (Direct) |
View |
| 2021-05-24 Option Award |
2021-05-25 7:03 pm |
N/A 2031-05-23 |
Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner |
16,500 | $0 | 16,500 (Direct) |
View |
| 2020-09-18 Conversion |
2020-09-22 5:10 pm |
N/A N/A |
Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner |
2,664,258 | $0 | 178,942 (Indirect) |
View |
Ownership |
2020-09-15 5:11 pm |
N/A N/A |
Metacrine Inc. | MTCR | Nashat Amir Director 10% Owner |
0 | $0 | 2,664,258 (Indirect) |
View |
| 2020-06-18 Option Award |
2020-06-19 6:20 pm |
N/A 2030-06-18 |
Morphic Holding Inc. | MORF | Nashat Amir Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2020-06-16 Option Award |
2020-06-18 4:24 pm |
N/A 2030-06-16 |
Scholar Rock Holding Corp | SRRK | Nashat Amir Director 10% Owner |
13,000 | $0 | 13,000 (Direct) |
View |
| 2020-06-11 Option Award |
2020-06-11 4:52 pm |
N/A 2030-06-10 |
Syros Pharmaceuticals Inc. | SYRS | Nashat Amir Director |
17,500 | $0 | 17,500 (Direct) |
View |